The fully linked HTML version of this article has now been published.
Development ePress online publication date 1 Jun 2005
doi: 10.1242/dev.01864
Research article
Essential role of protein kinase B
(PKB
/Akt3) in postnatal brain development but not in glucose homeostasis
Oliver Tschopp,
Zhong-Zhou Yang,
Daniela Brodbeck,
Bettina A. Dummler,
Maja Hemmings-Mieszczak,
Takashi Watanabe,
Thomas Michaelis,
Jens Frahm,
and
Brian A. Hemmings*
* Author for correspondence (e-mail: brian.hemmings{at}fmi.ch)
Protein kinase B is implicated in many crucial cellular processes, such as metabolism, apoptosis and cell proliferation. In contrast to Pkb
and Pkb
-deficient mice, Pkb
-/- mice are viable, show no growth retardation and display normal glucose metabolism. However, in adult Pkb
mutant mice, brain size and weight are dramatically reduced by about 25%. In vivo magnetic resonance imaging confirmed the reduction of Pkb
-/- brain volumes with a proportionally smaller ventricular system. Examination of the major brain structures revealed no anatomical malformations except for a pronounced thinning of white matter fibre connections in the corpus callosum. The reduction in brain weight of Pkb
-/- mice is caused, at least partially, by a significant reduction in both cell size and cell number. Our results provide novel insights into the physiological role of PKB
and suggest a crucial role in postnatal brain development.
This article has been cited by other articles:

|
 |

|
 |
 
M. Degtyarev, A. De Maziere, C. Orr, J. Lin, B. B. Lee, J. Y. Tien, W. W. Prior, S. van Dijk, H. Wu, D. C. Gray, et al.
Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents
J. Cell Biol.,
October 6, 2008;
183(1):
101 - 116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Matthews, M. J. Taggart, and M. Westwood
Modulation of Caveolin-1 Expression Can Affect Signalling through the Phosphatidylinositol 3-Kinase/Akt Pathway and Cellular Proliferation in Response to Insulin-Like Growth Factor I
Endocrinology,
October 1, 2008;
149(10):
5199 - 5208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. L. Wright, I. G. Maroulakou, J. Eldridge, T. L. Liby, V. Sridharan, P. N. Tsichlis, and R. C. Muise-Helmericks
VEGF stimulation of mitochondrial biogenesis: requirement of AKT3 kinase
FASEB J,
September 1, 2008;
22(9):
3264 - 3275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Litherland, C. Dixon, R. L. Lakey, T. Robson, D. Jones, D. A. Young, T. E. Cawston, and A. D. Rowan
Synergistic Collagenase Expression and Cartilage Collagenolysis Are Phosphatidylinositol 3-Kinase/Akt Signaling-dependent
J. Biol. Chem.,
May 23, 2008;
283(21):
14221 - 14229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Meikle, K. Pollizzi, A. Egnor, I. Kramvis, H. Lane, M. Sahin, and D. J. Kwiatkowski
Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function
J. Neurosci.,
May 21, 2008;
28(21):
5422 - 5432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Bayascas, S. Wullschleger, K. Sakamoto, J. M. Garcia-Martinez, C. Clacher, D. Komander, D. M. F. van Aalten, K. M. Boini, F. Lang, C. Lipina, et al.
Mutation of the PDK1 PH Domain Inhibits Protein Kinase B/Akt, Leading to Small Size and Insulin Resistance
Mol. Cell. Biol.,
May 15, 2008;
28(10):
3258 - 3272.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Matsumoto, R. E. Straub, S. Marenco, K. K. Nicodemus, S.-i. Matsumoto, A. Fujikawa, S. Miyoshi, M. Shobo, S. Takahashi, J. Yarimizu, et al.
The evolutionarily conserved G protein-coupled receptor SREB2/GPR85 influences brain size, behavior, and vulnerability to schizophrenia
PNAS,
April 22, 2008;
105(16):
6133 - 6138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Rhodes, D. A. Heerding, D. R. Duckett, D. J. Eberwein, V. B. Knick, T. J. Lansing, R. T. McConnell, T. M. Gilmer, S.-Y. Zhang, K. Robell, et al.
Characterization of an Akt Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity
Cancer Res.,
April 1, 2008;
68(7):
2366 - 2374.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. F. Franke
Akt-interacting proteins: attractive opposites. Focus on "Carboxy-terminal modulator protein induces Akt phosphorylation and activation, thereby enhancing antiapoptotic, glycogen synthetic, and glucose uptake pathways"
Am J Physiol Cell Physiol,
December 1, 2007;
293(6):
C1768 - C1770.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Logie, A. J. Ruiz-Alcaraz, M. Keane, Y. L. Woods, J. Bain, R. Marquez, D. R. Alessi, and C. Sutherland
Characterization of a Protein Kinase B Inhibitor In Vitro and in Insulin-Treated Liver Cells
Diabetes,
September 1, 2007;
56(9):
2218 - 2227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Hirsch, C. Costa, and E. Ciraolo
Phosphoinositide 3-kinases as a common platform for multi-hormone signaling
J. Endocrinol.,
August 1, 2007;
194(2):
243 - 256.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. F. L. O'Shaughnessy, J. C. Welti, J. C. Cooke, A. A. Avilion, B. Monks, M. J. Birnbaum, and C. Byrne
AKT-dependent HspB1 (Hsp27) Activity in Epidermal Differentiation
J. Biol. Chem.,
June 8, 2007;
282(23):
17297 - 17305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Li, R. E. Anderson, H. Tomita, R. Adler, X. Liu, D. J. Zack, and R. V. S. Rajala
Nonredundant Role of Akt2 for Neuroprotection of Rod Photoreceptor Cells from Light-Induced Cell Death
J. Neurosci.,
January 3, 2007;
27(1):
203 - 211.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. G. Maroulakou, W. Oemler, S. P. Naber, and P. N. Tsichlis
Akt1 Ablation Inhibits, whereas Akt2 Ablation Accelerates, the Development of Mammary Adenocarcinomas in Mouse Mammary Tumor Virus (MMTV)-ErbB2/Neu and MMTV-Polyoma Middle T Transgenic Mice
Cancer Res.,
January 1, 2007;
67(1):
167 - 177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. E. Cristiano, J. C. Chan, K. M. Hannan, N. A. Lundie, N. J. Marmy-Conus, I. G. Campbell, W. A. Phillips, M. Robbie, R. D. Hannan, and R. B. Pearson
A Specific Role for AKT3 in the Genesis of Ovarian Cancer through Modulation of G2-M Phase Transition
Cancer Res.,
December 15, 2006;
66(24):
11718 - 11725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Shiojima and K. Walsh
Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway
Genes & Dev.,
December 15, 2006;
20(24):
3347 - 3365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Heron-Milhavet, C. Franckhauser, V. Rana, C. Berthenet, D. Fisher, B. A. Hemmings, A. Fernandez, and N. J. C. Lamb
Only Akt1 Is Required for Proliferation, while Akt2 Promotes Cell Cycle Exit through p21 Binding
Mol. Cell. Biol.,
November 15, 2006;
26(22):
8267 - 8280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G.M. van Gorp, K. M. Pomeranz, K. U. Birkenkamp, R. C-Y. Hui, E. W-F. Lam, and P. J. Coffer
Chronic Protein Kinase B (PKB/c-akt) Activation Leads to Apoptosis Induced by Oxidative Stress-Mediated Foxo3a Transcriptional Up-regulation.
Cancer Res.,
November 15, 2006;
66(22):
10760 - 10769.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Dummler, O. Tschopp, D. Hynx, Z.-Z. Yang, S. Dirnhofer, and B. A. Hemmings
Life with a Single Isoform of Akt: Mice Lacking Akt2 and Akt3 Are Viable but Display Impaired Glucose Homeostasis and Growth Deficiencies
Mol. Cell. Biol.,
November 1, 2006;
26(21):
8042 - 8051.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Otaegi, M. J. Yusta-Boyo, E. Vergano-Vera, H. R. Mendez-Gomez, A. C. Carrera, J. L. Abad, M. Gonzalez, E. J. de la Rosa, C. Vicario-Abejon, and F. de Pablo
Modulation of the PI 3-kinase-Akt signalling pathway by IGF-I and PTEN regulates the differentiation of neural stem/precursor cells
J. Cell Sci.,
July 1, 2006;
119(13):
2739 - 2748.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Baudry, Z.-Z. Yang, and B. A. Hemmings
PKB{alpha} is required for adipose differentiation of mouse embryonic fibroblasts
J. Cell Sci.,
March 1, 2006;
119(5):
889 - 897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Granville, R. M. Memmott, J. J. Gills, and P. A. Dennis
Handicapping the Race to Develop Inhibitors of the Phosphoinositide 3-Kinase/Akt/Mammalian Target of Rapamycin Pathway
Clin. Cancer Res.,
February 1, 2006;
12(3):
679 - 689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Fayard, L. A. Tintignac, A. Baudry, and B. A. Hemmings
Protein kinase B/Akt at a glance
J. Cell Sci.,
December 15, 2005;
118(24):
5675 - 5678.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-Z. Yang, O. Tschopp, N. Di-Poi, E. Bruder, A. Baudry, B. Dummler, W. Wahli, and B. A. Hemmings
Dosage-Dependent Effects of Akt1/Protein Kinase B{alpha} (PKB{alpha}) and Akt3/PKB{gamma} on Thymus, Skin, and Cardiovascular and Nervous System Development in Mice
Mol. Cell. Biol.,
December 1, 2005;
25(23):
10407 - 10418.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2005